Rowland & CO Investment Counsel Bio Rad Laboratories, Inc. Transaction History
Rowland & CO Investment Counsel
- $468 Million
- Q1 2025
A detailed history of Rowland & CO Investment Counsel transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 668 shares of BIO stock, worth $152,290. This represents 0.03% of its overall portfolio holdings.
Number of Shares
668
Previous 853
21.69%
Holding current value
$152,290
Previous $280,000
42.14%
% of portfolio
0.03%
Previous 0.06%
Shares
19 transactions
Others Institutions Holding BIO
# of Institutions
462Shares Held
18.9MCall Options Held
12.7KPut Options Held
14.4K-
Vanguard Group Inc Valley Forge, PA1.91MShares$436 Million0.01% of portfolio
-
First Eagle Investment Management, LLC1.57MShares$357 Million0.8% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$353 Million0.01% of portfolio
-
Veritas Asset Management LLP913KShares$208 Million2.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX877KShares$200 Million0.05% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $5.62B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...